Werbung
Werbung

ARMP

ARMP logo

Armata Pharmaceuticals, Inc. Common Stock

7.00
USD
Gesponsert
-0.89
-11.23%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

6.88

-0.13
-1.84%

ARMP Ergebnisberichte

Positives Überraschungsverhältnis

ARMP übertreffen die 20 der letzten 38Schätzungen.

53%

Nächster Bericht

Datum des nächsten Berichts
18. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.53M
/
-$0.19
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+32.01%
/
-74.32%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+23.89%
/
-371.43%

Armata Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On 12. Nov. 2025, ARMP reported earnings of -0.74 USD per share (EPS) for Q3 25, missing the estimate of -0.42 USD, resulting in a -72.74% surprise. Revenue reached 1.16 million, compared to an expected 1.41 million, with a -17.66% difference. The market reacted with a -4.63% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.19 USD, with revenue projected to reach 1.53 million USD, implying an decrease of -74.32% EPS, and increase of 32.01% in Revenue from the last quarter.
FAQ
For Q3 2025, Armata Pharmaceuticals, Inc. Common Stock reported EPS of -$0.74, missing estimates by -72.74%, and revenue of $1.16M, -17.66% below expectations.
The stock price moved down -4.63%, changed from $6.69 before the earnings release to $6.38 the day after.
The next earning report is scheduled for 18. März 2026.
Based on 3 analysts, Armata Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.19 and revenue of $1.53M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung